LOURES, Portugal, April 17 Hovione announced today thelaunch of its new website http://www.hovione.com. The fully re-designedwebsite provides in-depth and up-to-date information on the Hovione Group.
This updated site reflects Hovione's new business structure organizedinto four Business Units: Generics, Exclusives, Particle Design andInhalation. The website is highly informative and comprehensive, howeverinformation is easy to find and navigation intuitive.
"The purpose of the re-design is to better reflect our updated offering.Hovione is well known for its portfolio of difficult to make generic APIs,for its long experience in development and synthesis of exclusive APIs forinnovators - the new website reflects the fact that we have two new highgrowth areas: Particle Design and Inhalation Formulation Services," said GuyVillax, Hovione CEO.
Hovione is an international group specializing in the development andcompliant manufacture of active pharmaceutical ingredients, servingexclusively the pharmaceutical industry. With sales of US$100 million and a50-year track record, Hovione offers advanced technologies as well as APIsfor all drug delivery systems, from oral to injectable and from inhalation totopical applications. With FDA inspected plants in Europe, the Far East andthe US, Hovione is committed to the highest levels of service and quality.Specializing in complex chemistry and in particle engineering, Hovione offersall services related to the development, manufacture and pre-formulation ofboth new chemical entities (NCEs) and existing APIs for off-patent products.
For further information about Hovione, please visit the Hovione site athttp://www.hovione.com or contact Corporate Communications (Isabel Pina,+351-21-982-9362, e-mail: [email protected]